Don't Miss this: Getting to Know the Abecma (ide-cel) CAR T Therapy MC Community Event

The newly FDA-approved treatment, Abecma (ide-cel) CAR T Therapy, has been a popular topic of myeloma-based meetings and articles in recent months. So what will make this upcoming event in the Myeloma Crowd Community any different? 

We wanted to take a more basic approach when considering the CAR T therapy. We will explore practical questions surrounding CAR T therapy such as: 

• What is the treatment? 
• How does it work? 
• Who is it for? 
• What is the procedure like? 
• Who qualifies for it? 
• How can you sign up? 
• What is recovery like? 

And to answer these questions we have multiple myeloma specialist, Dr. Nina Shah from UCSF Health. With experience in the CAR T clinical trials, Dr. Shah has a unique perspective on the treatment and will be able to share her knowledge with us in a clear and precise way. 

Don't miss the chance to ask an expert your questions about this new and upcoming therapy. It could be a game-changer in your myeloma journey! 

Register Today!